• DRAMP ID

    • DRAMP04015
    • Peptide Name

    • LL-37V9 (LL-37 variants)
    • Source

    • Synthetic construct
    • Family

    • Not found
    • Gene

    • Not found
    • Sequence

    • LLGDFFRKVKEKIGKEFKRIVQRIKDFLRNLVPRTES
    • Sequence Length

    • 37
    • UniProt Entry

    • No entry found
    • Protein Existence

    • Synthetic
    • Biological Activity

    • Antimicrobial, Antibacterial, Anti-Gram-
    • Target Organism

      • Gram-negative bacteria: Escherichia coli DC2 (MIC=12 µM), Escherichia coli K12 (MIC=25 µM).
    • Hemolytic Activity

      • No hemolysis information or data found in the reference(s) presented in this entry
    • Cytotoxicity

      • Not included yet
    • Binding Target

    • Not found
    • Linear/Cyclic

    • Not included yet
    • N-terminal Modification

    • Not included yet
    • C-terminal Modification

    • Not included yet
    • Nonterminal Modifications and Unusual Amino Acids

    • Not included yet
    • Stereochemistry

    • Not included yet
    • Structure

    • Not found
    • Structure Description

    • Not found
    • Helical Wheel Diagram

    • DRAMP04015 helical wheel diagram
    • PDB ID

    • None
    • Predicted Structure

    • There is no predicted structure for DRAMP04015.
    • Formula

    • C207H344N60O52
    • Absent Amino Acids

    • ACHMWY
    • Common Amino Acids

    • K
    • Mass

    • 4505.38
    • PI

    • 10.61
    • Basic Residues

    • 11
    • Acidic Residues

    • 5
    • Hydrophobic Residues

    • 14
    • Net Charge

    • +6
    • Boman Index

    • -103.56
    • Hydrophobicity

    • -0.589
    • Aliphatic Index

    • 97.3
    • Half Life

      • Mammalian:5.5 hour
      • Yeast:3 min
      • E.coli:2 min
    • Extinction Coefficient Cystines

    • 0
    • Absorbance 280nm

    • 0
    • Polar Residues

    • 5

DRAMP04015

DRAMP04015 chydropathy plot
    • Function

    • Has antibacterial activiy against the Gram-negative bacterium E. coli.
  • ·Literature 1
    • Title

    • Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.
    • Reference

    • Biochemistry. 2012 Jan 17;51(2):653-664.
    • Author

    • Wang G, Elliott M, Cogen AL, Ezell EL, Gallo RL, Hancock RE.